Luke H. Stockwin

1.5k total citations
25 papers, 1.1k citations indexed

About

Luke H. Stockwin is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Luke H. Stockwin has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Luke H. Stockwin's work include CAR-T cell therapy research (4 papers), Cardiac tumors and thrombi (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Luke H. Stockwin is often cited by papers focused on CAR-T cell therapy research (4 papers), Cardiac tumors and thrombi (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Luke H. Stockwin collaborates with scholars based in United States, United Kingdom and Russia. Luke H. Stockwin's co-authors include Dianne L. Newton, Melinda G. Hollingshead, G. Eric Blair, Iain G. Martin, Chad N. Hancock, Dennis McGonagle, Suzanne Borgel, Bingnan Han, Lawrence R. Phillips and Tracy Wolfe and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Luke H. Stockwin

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke H. Stockwin United States 18 585 324 189 183 140 25 1.1k
Punit Saraon Canada 19 805 1.4× 236 0.7× 267 1.4× 152 0.8× 240 1.7× 25 1.5k
Maureen H. Beresini United States 22 560 1.0× 200 0.6× 168 0.9× 137 0.7× 112 0.8× 34 1.2k
Vrushank Davé United States 22 1.1k 1.9× 266 0.8× 191 1.0× 127 0.7× 435 3.1× 33 1.7k
Maciej Wieczorek Poland 20 831 1.4× 243 0.8× 139 0.7× 268 1.5× 120 0.9× 83 1.4k
Naijie Jing United States 21 1.1k 1.9× 521 1.6× 166 0.9× 196 1.1× 71 0.5× 38 1.6k
Corey P. Causey United States 22 1.1k 1.8× 466 1.4× 342 1.8× 689 3.8× 105 0.8× 37 2.0k
Finn C. Wiberg Denmark 21 1.3k 2.2× 448 1.4× 146 0.8× 201 1.1× 67 0.5× 32 2.1k
Benjamin A. Nacev United States 15 881 1.5× 322 1.0× 184 1.0× 76 0.4× 182 1.3× 34 1.2k
Shannon Marshall United States 21 726 1.2× 320 1.0× 63 0.3× 283 1.5× 89 0.6× 40 1.2k
Jonathan R. Hart United States 24 1.5k 2.5× 538 1.7× 312 1.7× 150 0.8× 102 0.7× 47 1.9k

Countries citing papers authored by Luke H. Stockwin

Since Specialization
Citations

This map shows the geographic impact of Luke H. Stockwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke H. Stockwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke H. Stockwin more than expected).

Fields of papers citing papers by Luke H. Stockwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke H. Stockwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke H. Stockwin. The network helps show where Luke H. Stockwin may publish in the future.

Co-authorship network of co-authors of Luke H. Stockwin

This figure shows the co-authorship network connecting the top 25 collaborators of Luke H. Stockwin. A scholar is included among the top collaborators of Luke H. Stockwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke H. Stockwin. Luke H. Stockwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gudmundsson, Kristbjorn O., Kimberly D. Klarmann, Satyendra Kumar Singh, et al.. (2018). POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression. Cell Reports. 23(11). 3236–3248. 23 indexed citations
3.
Hollingshead, Melinda G., Luke H. Stockwin, Sergio Y. Alcoser, et al.. (2014). Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies. BMC Genomics. 15(1). 393–393. 26 indexed citations
4.
Ye, Xiaoying, King C. Chan, DaRue A. Prieto, et al.. (2013). Trypsin-Mediated 18O/16O Labeling for Biomarker Discovery. Methods in molecular biology. 1002. 133–149. 2 indexed citations
5.
Newton, Dianne L., Luke H. Stockwin, Michael E. Mullendore, et al.. (2012). Abstract 2810: NSC 743380 induces apoptosis in sensitive cell lines through activation of tyrosine kinase 2 (Tyk2). Cancer Research. 72(8_Supplement). 2810–2810. 1 indexed citations
6.
Glaros, Trevor, et al.. (2012). The “survivin suppressants” NSC 80467 and YM155 induce a DNA damage response. Cancer Chemotherapy and Pharmacology. 70(1). 207–212. 83 indexed citations
7.
Kenney, Susan, David T. Vistica, Luke H. Stockwin, et al.. (2011). ASPS-1, A Novel Cell Line Manifesting Key Features of Alveolar Soft Part Sarcoma. Journal of Pediatric Hematology/Oncology. 33(5). 360–368. 17 indexed citations
8.
Orsburn, Benjamin C., Luke H. Stockwin, & Dianne L. Newton. (2011). Challenges in plasma membrane phosphoproteomics. Expert Review of Proteomics. 8(4). 483–494. 19 indexed citations
9.
Stockwin, Luke H., Suzanne Borgel, Chad N. Hancock, et al.. (2010). Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. International Journal of Cancer. 127(11). 2510–2519. 136 indexed citations
10.
Hancock, Chad N., Luke H. Stockwin, Bingnan Han, et al.. (2010). A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo. Free Radical Biology and Medicine. 50(1). 110–121. 98 indexed citations
11.
Stockwin, Luke H., Bingnan Han, Melinda G. Hollingshead, et al.. (2009). Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction. International Journal of Cancer. 125(6). 1266–1275. 87 indexed citations
12.
Stockwin, Luke H., David T. Vistica, Susan Kenney, et al.. (2009). Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC Cancer. 9(1). 22–22. 73 indexed citations
13.
Vistica, David T., Melinda G. Hollingshead, Suzanne Borgel, et al.. (2009). Therapeutic Vulnerability of an In Vivo Model of Alveolar Soft Part Sarcoma (ASPS) to Antiangiogenic Therapy. Journal of Pediatric Hematology/Oncology. 31(8). 561–570. 33 indexed citations
14.
Stockwin, Luke H., et al.. (2009). ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC. BMC Cancer. 9(1). 63–63. 23 indexed citations
15.
Newton, Dianne L., Luke H. Stockwin, & Susanna M. Rybak. (2008). Anti-CD22 Onconase: Preparation and Characterization. Methods in molecular biology. 525. 425–443. 7 indexed citations
16.
Stockwin, Luke H., Josip Blonder, David A. Lucas, et al.. (2006). Proteomic Analysis of Plasma Membrane from Hypoxia-Adapted Malignant Melanoma. Journal of Proteome Research. 5(11). 2996–3007. 55 indexed citations
17.
Steers, Graham, Luke H. Stockwin, Benjamin I. Leach, et al.. (2006). CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. British Journal of Cancer. 95(3). 298–306. 40 indexed citations
18.
Liu, Hui, Gregory C. Ippolito, Baeck-Seung Lee, et al.. (2006). Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Molecular Cancer. 5(1). 18–18. 68 indexed citations
19.
Pandha, Hardev, Luke H. Stockwin, J.D. Eaton, et al.. (2003). Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies. Prostate Cancer and Prostatic Diseases. 6(1). 6–11. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Punit Saraon Breakdown of academic impact, for papers by Maureen H. Beresini Breakdown of academic impact, for papers by Vrushank Davé Breakdown of academic impact, for papers by Maciej Wieczorek Breakdown of academic impact, for papers by Naijie Jing Breakdown of academic impact, for papers by Corey P. Causey Breakdown of academic impact, for papers by Finn C. Wiberg Breakdown of academic impact, for papers by Benjamin A. Nacev Breakdown of academic impact, for papers by Shannon Marshall Breakdown of academic impact, for papers by Jonathan R. Hart
Rankless by CCL
2026